ArticleFrontiers in pediatrics2026
Efficacy of a low-FODMAP diet in children with irritable bowel syndrome and functional abdominal pain-not otherwise specified: a randomized controlled trial with early termination.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04528914 (Effect of a Low-FODMAP Diet for the Management of Functional Abdominal Pain Disorders in Children), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effect of a Low-FODMAP Diet for the Management of Functional Abdominal Pain Disorders in Children
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Evidence supporting the effectiveness of a low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (low-FODMAP) diet in treating functional abdominal pain disorders remains limited. We aimed to assess the efficacy of a low-FODMAP diet compared with a regular diet for management of children with irritable bowel syndrome (IBS) and functional abdominal pain-not otherwise specified (FAP-NOS). Methods: This randomized controlled trial enrolled children aged 8-18 years with IBS or FAP-NOS, diagnosed using the Rome IV criteria. Participants were assigned to a 4-week low-FODMAP diet or a regular diet. The primary outcome was the proportion of responders, defined as those with a ≥30% reduction in abdominal pain, corresponding to at least the Reliable Change Index (≥25 mm change on visual analog scale), over the 4-week intervention. Results: The trial was terminated early due to recruitment challenges. Of the 74 originally planned participants, 42 (57%) were randomized, and 38 (51%) received the intervention, with 19 in each group. In the available case analysis (including only participants with outcome data at week 4), there was no difference in the proportion of responders between the low-FODMAP (7/13) and regular diet (5/13) groups at week 4 [relative risk 1.4 mm, 95% confidence interval (CI), 0.6-3.3]. In the secondary outcomes, only a greater mean reduction in abdominal pain intensity was observed in the low-FODMAP diet group at week 4 (mean difference = -20.8 mm, 95% CI, -40.0 to -1.6; 26/38). Adverse events were rare in both groups ( Conclusions: This early-terminated RCT did not demonstrate a significant benefit of the low-FODMAP diet in increasing the proportion of responders among children with IBS and FAP-NOS. However, due to early termination and missing data, the findings should be interpreted with caution. Nonetheless, the study provides insights into challenges in conducting controlled dietary intervention trials in children (e.g., the demanding nature of a highly restricted dietary protocol and practical issues related to school settings and caregiver involvement), which may inform the design of future studies. Clinical Trial Registration: https://www.ClinicalTrials.gov Identifier: NCT04528914.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.